Linkedin X-twitter Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice

Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

Marketplace

GA-map IBS dysbiosis test, 1/14

January 2014—Norwegian molecular diagnostics company Genetic Analysis has launched its GA-map IBS Dysbiosis Test. The DNA-based test makes it possible to effectively and routinely analyze the composition of the gut microbiota (bacteria profile) and any dysbiosis. The GA-map IBS Dysbiosis Test can be run in any molecular diagnostics laboratory. Target DNA is first isolated from patient stool samples. Then conserved regions of the bacterial 16S rRNA gene are used as templates to amplify the more variable regions in-between that are

Revised electronic sensor product guide, 12/13

December 2013—Mettler Toledo released the latest version of its interactive, Web-based Electrode ValueBox. This downloadable electrode identification and troubleshooting toolkit features a revised electronic sensor product guide to help Mettler Toledo customers choose the right electrode, saving time and enhancing accuracy when pH and other values are critical to experiment outcomes and product consistency.

Ventana, Incyte team up for companion diagnostics, 12/13

December 2013—Ventana Medical Systems has entered into an agreement with Incyte to collaborate on the development of companion diagnostic tests for Incyte’s oncology drug programs, beginning with the Incyte IDO1 inhibitor program.

Biosearch acquires majority stake in LightSpeed, 12/13

December 2013—Biosearch Technologies has acquired a majority stake in LightSpeed Genomics, a company developing an innovative optical-detection solution for the life science and diagnostics industry based on its proprietary Synthetic Aperture Optics (SAO) technology. Biosearch and LightSpeed are collaborators on the development of StellarVision, a next-generation gene-expression platform optimized to work seamlessly with Biosearch’s Stellaris RNA FISH assays to detect and quantify single-molecule RNA targets within individual cells.

SLAS expands global operations, 12/13

December 2013—The Society for Laboratory Automation and Screening, an international community of more than 15,000 scientists, engineers, researchers, technologists, and others from academic, government, and commercial laboratories, announced the opening of a European office in Brussels, Belgium. SLAS’ European office becomes the society’s third on three continents, joining operations in Shanghai, China, and its global headquarters in the United States.

Automated and expandable pipetting platform, 12/13

December 2013—Hamilton Robotics has launched a next-generation, liquid-handling platform that offers contact-free pipetting over a wide volume range. The Hamilton Vantage is space efficient, affordable, and can be remotely monitored by mobile devices. Its expandable design makes it a powerful instrument for labs performing simple or complex applications.

Validation of blood test for heart transplant rejection, 12/13

December 2013—The Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and HTG Molecular Diagnostics are collaborating to begin clinical validation of a biomarker blood test that will provide early indication of organ rejection in heart transplant patients and thereby allow doctors to better monitor and treat patients post-transplant. It is the first clinical validation study of this kind in Canada.

Ductless fume hoods, 12/13

December 2013—New Purair 5 ductless fume hoods from Air Science USA feature a high level of operator protection where routine work is being carried out. The units exceed OSHA, ANSI, and all relevant international standards, operate at low noise levels, and recirculate rather than exhaust expensive conditioned or heated air into the atmosphere.

Sequenom certified service provider program, 12/13

December 2013—Sequenom has announced a certified service provider program for the technical certification of selected laboratories offering research services using the Sequenom research-use-only MassArray system. Certifications cover the major research applications of the MassArray system, including iPlex genotyping, OncoCarta somatic mutation profiling, ADME PGx, and EpiTyper DNA methylation analysis.

Updated method evaluation document from CLSI, 12/13

December 2013—The Clinical and Laboratory Standards Institute has released the latest version of a document addressing the design of measurement procedure comparisons using patient samples and subsequent data-analysis techniques for determining the bias between two in vitro diagnostic measurement procedures.

MARKETPLACE

TRENDING